PDS Biotechnology Corpora...

NASDAQ: PDSB · Real-Time Price · USD
1.20
0.00 (0.00%)
At close: Aug 15, 2025, 3:59 PM
1.22
1.66%
After-hours: Aug 15, 2025, 07:12 PM EDT

PDS Biotechnology Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-37.61M -42.94M -40.85M -16.92M
Depreciation & Amortization
21.11K 17.36K 86.00 5.36K
Stock-Based Compensation
6.85M 7.61M 5.2M 4.11M
Other Working Capital
-453.77K -5.96M 4.57M 181.64K
Other Non-Cash Items
1.46M 3.84M 5.47M 240.82K
Deferred Income Tax
n/a -1.97M n/a n/a
Change in Working Capital
-5.75M -199K 4.47M 75.82K
Operating Cash Flow
-35.03M -33.64M -25.71M -12.49M
Capital Expenditures
-29K -4 -4 -4
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a 4.00 n/a n/a
Investing Cash Flow
-29K n/a n/a n/a
Debt Repayment
-3.18M -59.3K 25M n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
774K 308.3K 9.56M 344K
Financial Cash Flow
20.19M 16.38M 34.29M 48.89M
Net Cash Flow
-14.87M -17.26M 8.58M 36.4M
Free Cash Flow
-35.06M -33.64M -25.71M -12.49M